Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study
2020 · Clinical & Translational Immunology · 171 citations
https://doi.org/10.1002/cti2.1192
L
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
140
Papers
3.0K
Citations
28
h-index
60
i10-index
Li Zhong is an academic researcher from Northwest Institute of Mechanical and Electrical Engineering. The author has contributed to research in topics: Ubiquitin and proteasome pathways & MicroRNA in disease regulation & Cancer-related molecular mechanisms research. The author has an h-index of 28, co-authored 119 publications.
ORCID: 0000-0002-1646-2862Papers by this author
worksTargeting the CK1α/CBX4 axis for metastasis in osteosarcoma
2020 · Nature Communications · 156 citations
https://doi.org/10.1038/s41467-020-14870-4
Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes
2021 · Signal Transduction and Targeted Therapy · 129 citations
https://doi.org/10.1038/s41392-020-00414-1
Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity
2022 · Cell Research · 86 citations
https://doi.org/10.1038/s41422-022-00731-w
Clinical Characteristics and Risk Factors Associated With Acute Kidney Injury Inpatient With Exertional Heatstroke: An Over 10-Year Intensive Care Survey
2021 · Frontiers in Medicine · 33 citations
https://doi.org/10.3389/fmed.2021.678434
Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients with COVID-19: A Multicenter Retrospective Cohort Study
2020 · medRxiv · 28 citations
https://doi.org/10.1101/2020.04.11.20061739
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat